Mutations in CDH10 that lead to a loss of expression are associated with pancreatic ductal adenocarcinoma and metastatic small-cell gallbladder neuroendocrine carcinoma 30,32. This evidence concerns the gene CDH10 and pancreatic ductal adenocarcinoma.